Navigation Links
Immucor to Present at Upcoming Investor Conferences
Date:9/8/2009

NORCROSS, Ga., Sept. 8 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will webcast its presentations at two upcoming investor conferences.

Immucor will present at the Robert W. Baird & Co. 2009 Healthcare Conference in New York, NY on Thursday, September 10, 2009 at 12:15 pm Eastern Time. Immucor will also present at the UBS Global Life Sciences Conference in New York, NY on Tuesday, September 22, 2009 at 10:30 am Eastern Time.

Both presentations will be available via a live, simultaneous webcast. Access to the presentations will be available through the "About Us - Investor Information" section at www.immucor.com. For those unable to listen to the live broadcast, a replay of the presentation will be available shortly after its completion and will be archived on Immucor's website for approximately 60 days.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Immucor Announces Fiscal Fourth Quarter Results
2. Immucor Appoints Chief Operating Officer
3. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
4. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
5. Immucor Announces Fiscal Year 2010 Guidance
6. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
7. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
8. Immucor Receives Subpoena From Department of Justice
9. Immucor Announces Fiscal Third Quarter Results
10. Immucor Announces New Vice President, Operations
11. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman ... and outserts. As a means of expanding capabilities Flottman has added a ... to individually code professional inserts (PIs) and patient package inserts (PPIs) that will ...
(Date:12/9/2016)... , ... December 09, 2016 , ... An inventor from ... to safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP ... is easy to use and could be set up in a matter of minutes, ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research ... Screening Market - Forecast to 2021" report to their ... ... of open innovative models in the pharmaceutical and biotechnology industry ... and rising government funding. Emerging markets and growing research activities ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
Breaking Medicine Technology: